{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:59:32Z","timestamp":1744736372691},"reference-count":32,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2011]]},"DOI":"10.1620\/tjem.224.91","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T06:06:02Z","timestamp":1305785162000},"page":"91-97","source":"Crossref","is-referenced-by-count":5,"title":["Protective Effects of Anisodamine on Renal Function in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention"],"prefix":"10.1620","volume":"224","author":[{"given":"Yanbo","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghua","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuechao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwei","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinshun","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhen","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfa","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weize","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Chen, H.H. (2009) Atrial Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy: What's Old Is New But at the Right Dose and Duration of Therapy. <i>J. Am. Coll. Cardiol<\/i>., <b>53<\/b>, 1047-1049.","DOI":"10.1016\/j.jacc.2008.12.020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Fosb&oslash;l, E.L., Thune, J.J., Kelbaek, H., Andersen, H.R., Saunam&auml;ki, K., Nielsen, T.T., Mortensen, L.S. &amp; K&oslash;ber, L.; DANAMI-2 Investigators. (2008) Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: a Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy. <i>Am. Heart J<\/i>., <b>156<\/b>, 391-396.","DOI":"10.1016\/j.ahj.2008.04.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Fu, X.H., Fan, W.Z., Gu, X.S., Wei, Y.Y., Jiang, Y.F., Wu, W.L., Li, S.Q., Hao, G.Z., Wei, Q.M. &amp; Xue, L. (2007) Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction. <i>Chin. Med. J . (Engl).<\/i>, <b>120<\/b>, 1226-1231.","DOI":"10.1097\/00029330-200707020-00004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Kawashima, S., Takano, H., Iino, Y., Takayama, M. &amp; Takano, T. (2006) Prophylactic Hemodialysis Does Not Prevent Contrast-Induced Nephropathy after Cardiac Catheterization in Patients with Chronic Renal Insufficiency. <i>Circ. J.<\/i>, <b>70<\/b>, 553-558.","DOI":"10.1253\/circj.70.553"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Kelly, A.M., Dwamena, B., Cronin, P., Bernstein, S.J. &amp; Carlos, R.C. (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. <i>Ann. Intern. Med<\/i>., <b>148<\/b>, 284-294.","DOI":"10.7326\/0003-4819-148-4-200802190-00007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kowalczyk, J., Lenarczyk, R., Kowalski, O., Sredniawa, B., Musialik-Lydka, A., Gasior, M., Polonski, L., Zembala, M., Gumprecht, J. &amp; Kalarus, Z. (2007) Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention. <i>J. Interv. Cardiol.<\/i>, <b>20<\/b>, 143-152.","DOI":"10.1111\/j.1540-8183.2007.00253.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Levey, A.S., Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L., Hendriksen, S., Kusek, J.W. &amp; Van Lente, F.; Chronic Kidney Disease Epidemiology Collaboration. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. <i>Ann. Intern. Med.<\/i>, <b>145<\/b>, 247-254.","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.06.007"},{"key":"10","unstructured":"Liu, X. &amp; Zhang, J. (1998) An experimental study on the mechanism of anisodamini hydrobromidum in treating acute ischemic renal failure. <i>J. Tongji Med. Univ.<\/i>, <b>18<\/b>, 187-189."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Marenzi, G., Assanelli, E., Campodonico, J., Lauri, G., Marana, I., De Metrio, M., Moltrasio, M., Grazi, M., Rubino, M., Veglia, F., Fabbiocchi, F. &amp; Bartorelli, A.L. (2009) Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. <i>Ann Intern. Med.<\/i>, <b>150<\/b>, 170-177.","DOI":"10.7326\/0003-4819-150-3-200902030-00006"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.07.043"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-0368"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2009.00523.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"McCullough, P.A. &amp; Tumlin, J.A. (2009) Prostaglandin-based renal protection against contrast-induced acute kidney injury. <i>Circulation<\/i>, <b>120<\/b>, 1749-1751.","DOI":"10.1161\/CIRCULATIONAHA.109.902189"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Mehran, R. &amp; Nikolsky, E. (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. <i>Kidney Int. Suppl<\/i>., <b>100<\/b>, S11-15.","DOI":"10.1038\/sj.ki.5000368"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Morikawa, S., Sone, T., Tsuboi, H., Mukawa, H., Morishima, I., Uesugi, M., Moritav, Y., Numaguchi, Y., Okumura, K. &amp; Murohara, T. (2009) Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. <i>J. Am. Coll. Cardiol.<\/i>, <b>53<\/b>, 1040-1046.","DOI":"10.1016\/j.jacc.2008.10.061"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Nakagawa, S., Kushiya, K., Taneike, I., Imanishi, K., Uchiyama, T. &amp; Yamamoto, T. (2005) Specific inhibitory action of anisodamine against a Staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice. <i>Clin. Diagn. Lab. Immunol.<\/i>, <b>12<\/b>, 399-408.","DOI":"10.1128\/CDLI.12.3.399-408.2005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Norby, F.L. &amp; Ren, J. (2002) Anisodamine inhibits cardiac contraction and intracellular Ca2+ transients in isolated adult rat ventricular myocytes. <i>Eur. J. Pharmacol<\/i>., <b>439<\/b>, 21-25.","DOI":"10.1016\/S0014-2999(02)01374-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Poupko, J.M., Baskin, S.I. &amp; Moore, E. (2007) The pharmacological properties of anisodamine. <i>J. Appl. Toxicol<\/i>., <b>27<\/b>, 116-121.","DOI":"10.1002\/jat.1154"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Rohani, A. (2010) Effectiveness of aminophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. <i>Indian J. Nephrol<\/i>., <b>20<\/b>, 80-83.","DOI":"10.4103\/0971-4065.65300"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000103623.63687.21"},{"key":"23","unstructured":"Shammas, N.W., Kapalis, M.J., Harris, M., Mckinney, D. &amp; Coyne, E.P. (2001) Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures. <i>J. Invasive Cardiol<\/i>., <b>13<\/b>, 738-740."},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.08.091"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Wang, Y.X., Jia, Y.F., Chen, K.M. &amp; Morcos, S.K. (2001) Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers. <i>Br. J. Radiol.<\/i>, <b>74<\/b>, 1103-1108.","DOI":"10.1259\/bjr.74.888.741103"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-009-0058-5"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl535"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Xinwei, J., Xianghua, F., Jing, Z., Xinshun, G., Ling, X., Weize, F., Guozhen, H., Yunfa, J., Weili, W. &amp; Shiqiang, L. (2009) Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. <i>Am. J. Cardiol<\/i>., <b>104<\/b>, 519-524.","DOI":"10.1016\/j.amjcard.2009.04.014"},{"key":"29","unstructured":"Xiu, R.J., Hammerschmidt, D.E., Coppo, P.A. &amp; Jacob, H.S. (1982) Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock. <i>JAMA<\/i>, <b>247<\/b>, 1458-1460."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Zhang, J., Fu, X., Jia, X., Fan, X., Gu, X., Li, S., Wu, W., Fan, W., Su, J., Hao, G., Jiang, Y. &amp; Xue, L. (2010) B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention. <i>Acta Radiologica<\/i>, <b>51<\/b>, 641-648.","DOI":"10.3109\/02841851.2010.486804"},{"key":"31","unstructured":"Zou, A.P., Parekh, N. &amp; Steinhausen, M. (1990) Effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats. <i>Int. J. Microcirc. Clin. Exp<\/i>., <b>9<\/b>, 285-296."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Zoungas, S., Ninomiya, T., Huxley, R., Cass, A., Jardine, M., Gallagher, M., Patel, A., Vasheghani-Farahani, A., Sadigh, G. &amp; Perkovic, V. (2009) Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. <i>Ann. Intern. Med.<\/i>, <b>151<\/b>, 631-638.","DOI":"10.7326\/0003-4819-151-9-200911030-00008"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/224\/2\/224_2_91\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:43:15Z","timestamp":1619638995000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/224\/2\/224_2_91\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.224.91","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}